Lavik lab publishes a new paper on synthetic platelets


Figure 1: (a) Hemostatic nanoparticles. The particles contain a poly(lactic-co-glycolic acid) (PLGA) core functionalized with poly(ethylene glycol) (PEG) arms and RGD-based peptides that target the glycoprotein IIIb/IIa receptors on activated platelets. (b) SEM of liver clot pseudocolored to show blood cells (red), hemostatic nanoparticles (green) and the fibrin mesh that is critical for clot stability. (c) Survival at 1 hour post injury. The hemostatic nanoparticles (GRGDS) significantly improve survival compared to the saline injury control.

Our paper, on the use of synthetic platelets to stop bleeding in a model of blunt trauma was just accepted at Biomacromolecules. Congratulations to all of the authors!

Shoffstall, A., Atkins, K., Groynom, R., Varley, M., Everhart, L., Lashof-Sullivan, M., Martyn-Dow, B., Butler, R., Ustin, J., Lavik, E. Intravenous Hemostatic Nanoparticles Increase Survival Following Blunt Trauma Injury. Biomacromolecules. In press.


2 thoughts on “Lavik lab publishes a new paper on synthetic platelets

  1. I’m excited to find this website. I wanted to thank you for your time for this wonderful read!! I definitely savored every little bit of it and I have you book marked to check out new stuff on your site.

  2. I see a lot of interesting posts on your website. You have to
    spend a lot of time writing, i know how to save you a lot of work, there is
    a tool that creates unique, SEO friendly articles in couple of seconds, just type in google
    – k2 unlimited content

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s